A citation-based method for searching scientific literature

L Monnier, C Colette, S Dejager, D R Owens. Rev Endocr Metab Disord 2016
Times Cited: 16







List of co-cited articles
92 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity






Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
31

Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
Catherine Gorst, Chun Shing Kwok, Saadia Aslam, Iain Buchan, Evangelos Kontopantelis, Phyo K Myint, Grant Heatlie, Yoon Loke, Martin K Rutter, Mamas A Mamas. Diabetes Care 2015
218
31


Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.
Rodney A Hayward, Peter D Reaven, Wyndy L Wiitala, Gideon D Bahn, Domenic J Reda, Ling Ge, Madeline McCarren, William C Duckworth, Nicholas V Emanuele. N Engl J Med 2015
357
25


The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes.
Louis Monnier, Anne Wojtusciszyn, Claude Colette, David Owens. Diabetes Technol Ther 2011
109
25




Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
128
25

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
589
25

Association between hemoglobin A1c variability and subclinical coronary atherosclerosis in subjects with type 2 diabetes.
Hae Kyung Yang, Borami Kang, Seung-Hwan Lee, Kun-Ho Yoon, Byung-Hee Hwang, Kiyuk Chang, Kyungdo Han, Gunseog Kang, Jae Hyoung Cho. J Diabetes Complications 2015
18
25

Glycemic Variability on Continuous Glucose Monitoring System Correlates With Non-Culprit Vessel Coronary Plaque Vulnerability in Patients With First-Episode Acute Coronary Syndrome - Optical Coherence Tomography Study.
Masaomi Gohbara, Kiyoshi Hibi, Takayuki Mitsuhashi, Nobuhiko Maejima, Noriaki Iwahashi, Shunsuke Kataoka, Eiichi Akiyama, Kengo Tsukahara, Masami Kosuge, Toshiaki Ebina,[...]. Circ J 2016
33
25

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
131
25

Residual dysglycemia when at target HbA(1c) of 7% (53mmol/mol) in persons with type 2 diabetes.
L Monnier, C Colette, S Dejager, D Owens. Diabetes Res Clin Pract 2014
15
20

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
18



Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
B P Kovatchev, D J Cox, L A Gonder-Frederick, D Young-Hyman, D Schlundt, W Clarke. Diabetes Care 1998
216
18


Basal insulin and cardiovascular and other outcomes in dysglycemia.
Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle,[...]. N Engl J Med 2012
976
18

Design of FLAT-SUGAR: Randomized Trial of Prandial Insulin Versus Prandial GLP-1 Receptor Agonist Together With Basal Insulin and Metformin for High-Risk Type 2 Diabetes.
Jeffrey L Probstfield, Irl Hirsch, Kevin O'Brien, Barry Davis, Richard Bergenstal, Connie Kingry, Dori Khakpour, Sarah Pressel, Kelley R Branch, Matthew Riddle. Diabetes Care 2015
22
18


Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
18

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
18

Prediction of severe hypoglycemia.
Daniel J Cox, Linda Gonder-Frederick, Lee Ritterband, William Clarke, Boris P Kovatchev. Diabetes Care 2007
84
18

Glycemic variability: it's not just about A1C anymore!
Irl B Hirsch. Diabetes Technol Ther 2005
85
18

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
John M Lachin, Ionut Bebu, Richard M Bergenstal, Rodica Pop-Busui, F John Service, Bernard Zinman, David M Nathan. Diabetes Care 2017
78
18

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.
Allen B King, Athena Philis-Tsimikas, Eric S Kilpatrick, Irene H Langbakke, Kamilla Begtrup, Tina Vilsbøll. Diabetes Technol Ther 2017
12
25



Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
12


Evaluation of the Menarini-Arkray HA 8140 hemoglobin A1c analyzer.
W G John, F Braconnier, K Miedema, C Aulesa, G Piras. Clin Chem 1997
37
12

Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.
Chiara Fabris, Andrea Facchinetti, Giovanni Sparacino, Mattia Zanon, Stefania Guerra, Alberto Maran, Claudio Cobelli. Diabetes Technol Ther 2014
33
12



Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data.
Klaus-Dieter Kohnert, Peter Heinke, Gert Fritzsche, Lutz Vogt, Petra Augstein, Eckhard Salzsieder. Diabetes Technol Ther 2013
31
12


Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
12

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis,[...]. N Engl J Med 2015
12

Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs.
Bruno Guerci, Michèle Floriot, Philip Böhme, Danielle Durain, Muriel Benichou, Stéphanie Jellimann, Pierre Drouin. Diabetes Care 2003
102
12

Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia?
Teresa P Monsod, Daniel E Flanagan, Fran Rife, Rebecca Saenz, Sonia Caprio, Robert S Sherwin, William V Tamborlane. Diabetes Care 2002
126
12

5. Glycemic Targets.
. Diabetes Care 2016
157
12

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.